-
EP3109239
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3109239
| EP3109239 - AMINOPYRAZOLONE DERIVATIVE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 31.08.2018 Database last updated on 24.08.2024 | |
| Former | Grant of patent is intended Status updated on 30.11.2017 | ||
| Former | Request for examination was made Status updated on 25.11.2016 | Most recent event Tooltip | 31.08.2018 | Application deemed to be withdrawn | published on 03.10.2018 [2018/40] | Applicant(s) | For all designated states Daiichi Sankyo Company, Limited 3-5-1, Nihonbashi Honcho Chuo-ku Tokyo 103-8426 / JP | [2016/52] | Inventor(s) | 01 /
EBISAWA, Masayuki c/o DAIICHI SANKYO COMPANY LIMITED 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | 02 /
SUZUKI, Takashi c/o DAIICHI SANKYO COMPANY LIMITED 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | 03 /
HAGINOYA, Noriyasu c/o DAIICHI SANKYO COMPANY LIMITED 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | 04 /
HAMADA, Tomoaki c/o DAIICHI SANKYO COMPANY LIMITED 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | 05 /
MURATA, Takeshi c/o DAIICHI SANKYO COMPANY LIMITED 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | 06 /
UOTO, Kouichi c/o DAIICHI SANKYO COMPANY LIMITED 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | 07 /
MURAKAMI, Ryo c/o DAIICHI SANKYO COMPANY LIMITED 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | 08 /
TAKATA, Takehiko c/o DAIICHI SANKYO COMPANY LIMITED 1-2-58 Hiromachi Shinagawa-ku Tokyo 140-8710 / JP | [2016/52] | Representative(s) | Fairbairn, Angus Chisholm Marks & Clerk LLP 15 Fetter Lane London EC4A 1BW / GB | [N/P] |
| Former [2016/52] | Fairbairn, Angus Chisholm Marks & Clerk LLP 90 Long Acre London WC2E 9RA / GB | Application number, filing date | 15752236.8 | 17.02.2015 | [2016/52] | WO2015JP54318 | Priority number, date | JP20140028990 | 18.02.2014 Original published format: JP 2014028990 | [2016/52] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015125786 | Date: | 27.08.2015 | Language: | JA | [2015/34] | Type: | A1 Application with search report | No.: | EP3109239 | Date: | 28.12.2016 | Language: | EN | [2016/52] | Search report(s) | International search report - published on: | JP | 27.08.2015 | (Supplementary) European search report - dispatched on: | EP | 06.06.2017 | Classification | IPC: | C07D231/50, C07D401/04, C07D401/12, C07D401/14, C07D403/12, C07D405/12, C07D405/14, C07D413/12, A61K31/4152, A61K31/4155, A61K31/423, A61K31/4439, A61K31/444, A61K31/4709, A61K31/5377, A61K31/538, A61P35/00, A61P43/00 | [2017/27] | CPC: |
C07D405/14 (EP,KR,US);
C07D231/50 (EP,KR,US);
A61K31/4152 (KR);
A61K31/4155 (KR);
A61K31/423 (KR);
A61K31/4439 (KR);
A61P1/04 (EP);
A61P1/16 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P13/08 (EP);
A61P13/10 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P17/00 (EP);
A61P19/08 (EP);
A61P25/00 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P43/00 (EP);
A61P7/00 (EP);
C07D401/04 (EP,KR,US);
C07D401/12 (EP,KR,US);
C07D401/14 (EP,KR,US);
|
| Former IPC [2016/52] | C07D231/50, A61K31/4152, A61K31/4155, A61K31/423, A61K31/4439, A61K31/444, A61K31/4709, A61K31/5377, A61K31/538, A61P35/00, A61P43/00, C07D401/04, C07D401/12, C07D401/14, C07D403/12, C07D405/12, C07D413/12 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/52] | Title | German: | AMINOPYRAZOLONDERIVAT | [2016/52] | English: | AMINOPYRAZOLONE DERIVATIVE | [2016/52] | French: | DÉRIVÉ DE L'AMINOPYRAZOLONE | [2016/52] | Entry into regional phase | 12.07.2016 | Translation filed | 12.07.2016 | National basic fee paid | 12.07.2016 | Search fee paid | 12.07.2016 | Designation fee(s) paid | 12.07.2016 | Examination fee paid | Examination procedure | 12.07.2016 | Examination requested [2016/52] | 12.07.2016 | Date on which the examining division has become responsible | 04.07.2017 | Amendment by applicant (claims and/or description) | 01.12.2017 | Communication of intention to grant the patent | 12.04.2018 | Application deemed to be withdrawn, date of legal effect [2018/40] | 18.05.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2018/40] | Fees paid | Renewal fee | 10.02.2017 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 28.02.2018 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]FR2164482 (ARIES ROBERT) [A] 1-9 * claim 1 *; | [A]FR2198488 (DYNACHIM SARL [FR]) [A] 1-8* claim 1 *; | [A]US5929067 (GERSPACHER MARC [CH], et al) [A] 1-9 * Eaxample 5/28, column 76 *; | [AD] - JUDITH ELKAIM ET AL, "First identification of small-molecule inhibitors of Pontin by combining virtual screening and enzymatic assay", BIOCHEMICAL JOURNAL, GB, (20120415), vol. 443, no. 2, doi:10.1042/BJ20111779, ISSN 0264-6021, pages 549 - 559, XP055374748 [AD] 1-14 * figure 4 * DOI: http://dx.doi.org/10.1042/BJ20111779 | International search | [A]WO2004106306 (UNIV ASTON [GB], et al) [A] 1-14 * , & US 2007/0185115 A1 & GB 312368 D & EP 1628963 A1 & CA 2527194 A *; | [A]WO2010075286 (UNIV WASHINGTON [US], et al) [A] 1-14 * , & US 2012/0046242 A1 *; | [A] - PATIL V et al., "synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivatives", European Journal of Medicinal Chemistry, (20100000), vol. 45, pages 4539 - 4544, XP002647098 [A] 1-14 DOI: http://dx.doi.org/10.1016/J.EJMECH.2010.07.014 |